The associated myeloid neoplasms often share KIT mutations and/or other genetic abnormalities with SM, whereas KIT mutations are not found in lymphoid or plasma cell neoplasms co-occurring with SM [10]. This evidence concerns the gene KIT and systemic mastocytosis.